<DOC>
	<DOCNO>NCT01250236</DOCNO>
	<brief_summary>Brimonidine , alpha-2 adrenoceptor agonist , effective safe medication widely use glaucoma treatment . Although known quickly take cornea follow topical administration cornea alpha-2 adrenoceptors study available impact brimonidine cornea . The aim study find 1. whether topical administration brimonidine result interaction corneal alpha-2 adrenoceptors term increase corneal thickness 2. whether difference response corneal epithelium , stroma endothelium show alpha-2 adrenoceptor stimulation .</brief_summary>
	<brief_title>Effect Brimonidine Corneal Thickness</brief_title>
	<detailed_description />
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>healthy , 1899 year , normal ophthalmologic history , consent participate study serious medical neurologic condition and/or regular use local systemic medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>brimonidine</keyword>
	<keyword>alpha-2 adrenoceptor</keyword>
	<keyword>cornea</keyword>
	<keyword>corneal thickness</keyword>
</DOC>